Fosfomycin Not Noninferior to Comparators for Bacteremic UTI
Fosfomycin not noninferior to ceftriaxone or meropenem for bacteremic urinary tract infection due to multidrug-resistant E. coli in adults
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.